TY - JOUR T1 - A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales JO - Value in Health PY - -0001/11/30 AU - Rafia R AU - Metry A AU - Wailoo A ED - PB - Elsevier Y2 - 2025/04/09 ER -